Robert Susick
Inventor
Stats
- 0 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 6 US Applications Filed
- 1 Total Citation Count
- Apr 17, 2024 Most Recent Filing
- Aug 20, 2019 Earliest Filing
Work History
No Work History Available.Inventor Addresses
| Address | Duration |
|---|---|
| Oakland, CA, US | Oct 21, 21 - Oct 21, 21 |
| Wilmington, DE, US | Apr 13, 23 - Nov 28, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| B01J: | CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0390,340 | 2024 | PYRROLIDINE KRAS INHIBITORS | 0 |
| 2024/0368,152 | 2024 | QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS | 0 |
| 2023/0226,040 | 2023 | COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR | 0 |
| 2023/0144,051 | 2023 | QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS | 0 |
| 2023/0114,765 | 2023 | TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.